\renewcommand\arraystretch{0.6}\begin{longtable}{p{\textwidth}} \hline
 
\textbf{\emph{Group 1}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 0.940 (0.917,0.963)} \\ \textbf{Number of Cases = 41,358} \\ \textbf{Group contains the following 4 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 440 to 449: Diseases Of Arteries, Arterioles, And Capillaries} \\ \-\ \hspace{20pt}\footnotesize{-- 441: Aortic aneurysm and dissection} \\ \-\ \hspace{30pt}\footnotesize{-- 441.0: Dissection of aorta} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.00}}: Dissection of aorta, unspecified site (n=1,821)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.01}}: Dissection of aorta, thoracic (n=24,230)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.02}}: Dissection of aorta, abdominal (n=9,111)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.03}}: Dissection of aorta, thoracoabdominal (n=6,196)} \\  
 \hline 
 
 \textbf{\emph{Group 2}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 0.945 (0.926,0.965)} \\ \textbf{Number of Cases = 61,488} \\ \textbf{Group contains the following 1 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 430 to 438: Cerebrovascular Disease} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{430}}: Subarachnoid hemorrhage (n=61,488)} \\  
 \hline 
 
 \textbf{\emph{Group 3}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 0.949 (0.925,0.972)} \\ \textbf{Number of Cases = 39,902} \\ \textbf{Group contains the following 1 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 440 to 449: Diseases Of Arteries, Arterioles, And Capillaries} \\ \-\ \hspace{20pt}\footnotesize{-- 441: Aortic aneurysm and dissection} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.3}}: Abdominal aneurysm, ruptured (n=39,902)} \\  
 \hline 
 
 \textbf{\emph{Group 4}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 0.959 (0.930,0.988)} \\ \textbf{Number of Cases = 29,030} \\ \textbf{Group contains the following 1 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 430 to 438: Cerebrovascular Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 432: Other and unspecified intracranial hemorrhage} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{432.9}}: Unspecified intracranial hemorrhage (n=29,030)} \\  
 \hline 
 
 \textbf{\emph{Group 5}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 0.960 (0.951,0.969)} \\ \textbf{Number of Cases = 317,447} \\ \textbf{Group contains the following 1 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 430 to 438: Cerebrovascular Disease} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{431}}: Intracerebral hemorrhage (n=317,447)} \\  
 \hline 
 
 \textbf{\emph{Group 6}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 0.977 (0.968,0.986)} \\ \textbf{Number of Cases = 310,148} \\ \textbf{Group contains the following 3 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 401 to 405: Hypertensive Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 401: Essential hypertension} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{401.0}}: Malignant essential hypertension (n=93,928)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{401.1}}: Benign essential hypertension (n=1,980)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{401.9}}: Unspecified essential hypertension (n=214,240)} \\  
 \hline 
 
 \textbf{\emph{Group 7}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 1.011 (1.010,1.012)} \\ \textbf{Number of Cases = 19,056,207} \\ \textbf{Group contains the following 420 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 390 to 392: Acute Rheumatic Fever} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{390}}: Rheumatic fever without mention of heart involvement (n=371)} \\ \-\ \hspace{20pt}\footnotesize{-- 391: Rheumatic fever with heart involvement} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{391.0}}: Acute rheumatic pericarditis (n=252)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{391.1}}: Acute rheumatic endocarditis (n=427)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{391.8}}: Other acute rheumatic heart disease (n=1,339)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{391.9}}: Acute rheumatic heart disease, unspecified (n=29)} \\ \-\ \hspace{20pt}\footnotesize{-- 392: Rheumatic chorea} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{392.0}}: Rheumatic chorea with heart involvement (n=16)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{392.9}}: Rheumatic chorea without mention of heart involvement (n=21)} \\ \-\ \hspace{10pt}\footnotesize{-- 393 to 398: Chronic Rheumatic Heart Disease} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{393}}: Chronic rheumatic pericarditis (n=236)} \\ \-\ \hspace{20pt}\footnotesize{-- 394: Diseases of mitral valve} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{394.0}}: Mitral stenosis (n=2,086)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{394.1}}: Rheumatic mitral insufficiency (n=1,080)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{394.2}}: Mitral stenosis with insufficiency (n=1,749)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{394.9}}: Other and unspecified mitral valve diseases (n=312)} \\ \-\ \hspace{20pt}\footnotesize{-- 395: Diseases of aortic valve} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{395.0}}: Rheumatic aortic stenosis (n=917)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{395.1}}: Rheumatic aortic insufficiency (n=103)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{395.2}}: Rheumatic aortic stenosis with insufficiency (n=294)} \\ \-\ \hspace{20pt}\footnotesize{-- 396: Diseases of mitral and aortic valves} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{396.0}}: Mitral valve stenosis and aortic valve stenosis (n=3,293)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{396.1}}: Mitral valve stenosis and aortic valve insufficiency (n=612)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{396.2}}: Mitral valve insufficiency and aortic valve stenosis (n=20,739)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{396.3}}: Mitral valve insufficiency and aortic valve insufficiency (n=8,113)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{396.8}}: Multiple involvement of mitral and aortic valves (n=5,924)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{396.9}}: Mitral and aortic valve diseases, unspecified (n=332)} \\ \-\ \hspace{20pt}\footnotesize{-- 397: Diseases of other endocardial structures} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{397.0}}: Diseases of tricuspid valve (n=1,347)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{397.1}}: Rheumatic diseases of pulmonary valve (n=13)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{397.9}}: Rheumatic diseases of endocardium, valve unspecified (n=16)} \\ \-\ \hspace{20pt}\footnotesize{-- 398: Other rheumatic heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- 398.9: Other and unspecified rheumatic heart diseases} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{398.90}}: Rheumatic heart disease, unspecified (n=218)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{398.91}}: Rheumatic heart failure (congestive) (n=157,218)} \\ \-\ \hspace{10pt}\footnotesize{-- 401 to 405: Hypertensive Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 402: Hypertensive heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- 402.0: Malignant} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{402.00}}: Malignant hypertensive heart disease without heart failure (n=5,562)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{402.01}}: Malignant hypertensive heart disease with heart failure (n=13,419)} \\ \-\ \hspace{30pt}\footnotesize{-- 402.1: Benign} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{402.10}}: Benign hypertensive heart disease without heart failure (n=428)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{402.11}}: Benign hypertensive heart disease with heart failure (n=4,495)} \\ \-\ \hspace{30pt}\footnotesize{-- 402.9: Unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{402.90}}: Unspecified hypertensive heart disease without heart failure (n=18,681)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{402.91}}: Unspecified hypertensive heart disease with heart failure (n=252,868)} \\ \-\ \hspace{20pt}\footnotesize{-- 403: Hypertensive chronic kidney disease} \\ \-\ \hspace{30pt}\footnotesize{-- 403.0: Malignant} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{403.00}}: Hypertensive chronic kidney disease, malignant, with chronic kidney disease stage I through stage IV, or unspecified (n=19,641)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{403.01}}: Hypertensive chronic kidney disease, malignant, with chronic kidney disease stage V or end stage renal disease (n=16,084)} \\ \-\ \hspace{30pt}\footnotesize{-- 403.1: Benign} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{403.10}}: Hypertensive chronic kidney disease, benign, with chronic kidney disease stage I through stage IV, or unspecified (n=557)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{403.11}}: Hypertensive chronic kidney disease, benign, with chronic kidney disease stage V or end stage renal disease (n=1,724)} \\ \-\ \hspace{30pt}\footnotesize{-- 403.9: Unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{403.90}}: Hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage I through stage IV, or unspecified (n=40,096)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{403.91}}: Hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage V or end stage renal disease (n=157,489)} \\ \-\ \hspace{20pt}\footnotesize{-- 404: Hypertensive heart and chronic kidney disease} \\ \-\ \hspace{30pt}\footnotesize{-- 404.0: Malignant} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.00}}: Hypertensive heart and chronic kidney disease, malignant, without heart failure and with chronic kidney disease stage I through stage IV, or unspecified (n=1,231)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.01}}: Hypertensive heart and chronic kidney disease, malignant, with heart failure and with chronic kidney disease stage I through stage IV, or unspecified (n=7,471)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.02}}: Hypertensive heart and chronic kidney disease, malignant, without heart failure and with chronic kidney disease stage V or end stage renal disease (n=1,189)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.03}}: Hypertensive heart and chronic kidney disease, malignant, with heart failure and with chronic kidney disease stage V or end stage renal disease (n=7,507)} \\ \-\ \hspace{30pt}\footnotesize{-- 404.1: Benign} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.10}}: Hypertensive heart and chronic kidney disease, benign, without heart failure and with chronic kidney disease stage I through stage IV, or unspecified (n=53)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.11}}: Hypertensive heart and chronic kidney disease, benign, with heart failure and with chronic kidney disease stage I through stage IV, or unspecified (n=2,053)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.12}}: Hypertensive heart and chronic kidney disease, benign, without heart failure and with chronic kidney disease stage V or end stage renal disease (n=97)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.13}}: Hypertensive heart and chronic kidney disease, benign, with heart failure and chronic kidney disease stage V or end stage renal disease (n=1,505)} \\ \-\ \hspace{30pt}\footnotesize{-- 404.9: Unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.90}}: Hypertensive heart and chronic kidney disease, unspecified, without heart failure and with chronic kidney disease stage I through stage IV, or unspecified (n=2,088)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.91}}: Hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage I through stage IV, or unspecified (n=86,467)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.92}}: Hypertensive heart and chronic kidney disease, unspecified, without heart failure and with chronic kidney disease stage V or end stage renal disease (n=6,296)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{404.93}}: Hypertensive heart and chronic kidney disease, unspecified, with heart failure and chronic kidney disease stage V or end stage renal disease (n=91,392)} \\ \-\ \hspace{20pt}\footnotesize{-- 405: Secondary hypertension} \\ \-\ \hspace{30pt}\footnotesize{-- 405.0: Malignant} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{405.01}}: Malignant renovascular hypertension (n=1,370)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{405.09}}: Other malignant secondary hypertension (n=252)} \\ \-\ \hspace{30pt}\footnotesize{-- 405.1: Benign} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{405.11}}: Benign renovascular hypertension (n=50)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{405.19}}: Other benign secondary hypertension (n=19)} \\ \-\ \hspace{30pt}\footnotesize{-- 405.9: Unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{405.91}}: Unspecified renovascular hypertension (n=2,035)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{405.99}}: Other unspecified secondary hypertension (n=517)} \\ \-\ \hspace{10pt}\footnotesize{-- 410 to 414: Ischemic Heart Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 410: Acute myocardial infarction} \\ \-\ \hspace{30pt}\footnotesize{-- 410.0: Of anterolateral wall} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.00}}: Acute myocardial infarction of anterolateral wall, episode of care unspecified (n=277)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.01}}: Acute myocardial infarction of anterolateral wall, initial episode of care (n=67,408)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.02}}: Acute myocardial infarction of anterolateral wall, subsequent episode of care (n=354)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.1: Of other anterior wall} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.10}}: Acute myocardial infarction of other anterior wall, episode of care unspecified (n=1,771)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.11}}: Acute myocardial infarction of other anterior wall, initial episode of care (n=257,579)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.12}}: Acute myocardial infarction of other anterior wall, subsequent episode of care (n=1,415)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.2: Of inferolateral wall} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.20}}: Acute myocardial infarction of inferolateral wall, episode of care unspecified (n=161)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.21}}: Acute myocardial infarction of inferolateral wall, initial episode of care (n=52,231)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.22}}: Acute myocardial infarction of inferolateral wall, subsequent episode of care (n=252)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.3: Of inferoposterior wall} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.30}}: Acute myocardial infarction of inferoposterior wall, episode of care unspecified (n=107)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.31}}: Acute myocardial infarction of inferoposterior wall, initial episode of care (n=37,280)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.32}}: Acute myocardial infarction of inferoposterior wall, subsequent episode of care (n=156)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.4: Of other inferior wall} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.40}}: Acute myocardial infarction of other inferior wall, episode of care unspecified (n=819)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.41}}: Acute myocardial infarction of other inferior wall, initial episode of care (n=298,916)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.42}}: Acute myocardial infarction of other inferior wall, subsequent episode of care (n=1,287)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.5: Of other lateral wall} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.50}}: Acute myocardial infarction of other lateral wall, episode of care unspecified (n=109)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.51}}: Acute myocardial infarction of other lateral wall, initial episode of care (n=36,053)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.52}}: Acute myocardial infarction of other lateral wall, subsequent episode of care (n=155)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.6: True posterior wall infarction} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.61}}: True posterior wall infarction, initial episode of care (n=10,521)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.62}}: True posterior wall infarction, subsequent episode of care (n=39)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.7: Subendocardial infarction} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.70}}: Subendocardial infarction, episode of care unspecified (n=4,118)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.71}}: Subendocardial infarction, initial episode of care (n=1,911,598)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.72}}: Subendocardial infarction, subsequent episode of care (n=7,434)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.8: Of other specified sites} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.80}}: Acute myocardial infarction of other specified sites, episode of care unspecified (n=265)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.81}}: Acute myocardial infarction of other specified sites, initial episode of care (n=49,289)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.82}}: Acute myocardial infarction of other specified sites, subsequent episode of care (n=323)} \\ \-\ \hspace{30pt}\footnotesize{-- 410.9: Unspecified site} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.90}}: Acute myocardial infarction of unspecified site, episode of care unspecified (n=3,556)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.91}}: Acute myocardial infarction of unspecified site, initial episode of care (n=225,027)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{410.92}}: Acute myocardial infarction of unspecified site, subsequent episode of care (n=1,479)} \\ \-\ \hspace{20pt}\footnotesize{-- 411: Other acute and subacute forms of ischemic heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{411.0}}: Postmyocardial infarction syndrome (n=3,906)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{411.1}}: Intermediate coronary syndrome (n=176,855)} \\ \-\ \hspace{30pt}\footnotesize{-- 411.8: Other} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{411.81}}: Acute coronary occlusion without myocardial infarction (n=3,306)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{411.89}}: Other acute and subacute forms of ischemic heart disease, other (n=20,225)} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{412}}: Old myocardial infarction (n=159)} \\ \-\ \hspace{20pt}\footnotesize{-- 413: Angina pectoris} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{413.0}}: Angina decubitus (n=182)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{413.1}}: Prinzmetal angina (n=2,242)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{413.9}}: Other and unspecified angina pectoris (n=88,764)} \\ \-\ \hspace{20pt}\footnotesize{-- 414: Other forms of chronic ischemic heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- 414.0: Coronary atherosclerosis} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.00}}: Coronary atherosclerosis of unspecified type of vessel, native or graft (n=327,733)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.01}}: Coronary atherosclerosis of native coronary artery (n=2,257,823)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.02}}: Coronary atherosclerosis of autologous vein bypass graft (n=113,806)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.03}}: Coronary atherosclerosis of nonautologous biological bypass graft (n=348)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.04}}: Coronary atherosclerosis of artery bypass graft (n=10,782)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.05}}: Coronary atherosclerosis of unspecified bypass graft (n=12,384)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.06}}: Coronary atherosclerosis of native coronary artery of transplanted heart (n=302)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.07}}: Coronary atherosclerosis of bypass graft (artery) (vein) of transplanted heart (n=34)} \\ \-\ \hspace{30pt}\footnotesize{-- 414.1: Aneurysm and dissection of heart} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.10}}: Aneurysm of heart (wall) (n=1,238)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.11}}: Aneurysm of coronary vessels (n=370)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.12}}: Dissection of coronary artery (n=277)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.19}}: Other aneurysm of heart (n=138)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.8}}: Other specified forms of chronic ischemic heart disease (n=42,310)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{414.9}}: Chronic ischemic heart disease, unspecified (n=7,433)} \\ \-\ \hspace{10pt}\footnotesize{-- 415 to 417: Diseases Of Pulmonary Circulation} \\ \-\ \hspace{20pt}\footnotesize{-- 415: Acute pulmonary heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{415.0}}: Acute cor pulmonale (n=10,084)} \\ \-\ \hspace{30pt}\footnotesize{-- 415.1: Pulmonary embolism and infarction} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{415.11}}: Iatrogenic pulmonary embolism and infarction (n=22,759)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{415.13}}: Saddle embolus of pulmonary artery (n=1,860)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{415.19}}: Other pulmonary embolism and infarction (n=501,194)} \\ \-\ \hspace{20pt}\footnotesize{-- 416: Chronic pulmonary heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{416.0}}: Primary pulmonary hypertension (n=5,586)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{416.1}}: Kyphoscoliotic heart disease (n=24)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{416.2}}: Chronic pulmonary embolism (n=964)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{416.8}}: Other chronic pulmonary heart diseases (n=35,681)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{416.9}}: Chronic pulmonary heart disease, unspecified (n=9,355)} \\ \-\ \hspace{20pt}\footnotesize{-- 417: Other diseases of pulmonary circulation} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{417.0}}: Arteriovenous fistula of pulmonary vessels (n=164)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{417.1}}: Aneurysm of pulmonary artery (n=193)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{417.8}}: Other specified diseases of pulmonary circulation (n=613)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{417.9}}: Unspecified disease of pulmonary circulation (n=10)} \\ \-\ \hspace{10pt}\footnotesize{-- 420 to 429: Other Forms Of Heart Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 420: Acute pericarditis} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{420.0}}: Acute pericarditis in diseases classified elsewhere (n=2)} \\ \-\ \hspace{30pt}\footnotesize{-- 420.9: Other and unspecified acute pericarditis} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{420.90}}: Acute pericarditis, unspecified (n=20,149)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{420.91}}: Acute idiopathic pericarditis (n=9,373)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{420.99}}: Other acute pericarditis (n=2,631)} \\ \-\ \hspace{20pt}\footnotesize{-- 421: Acute and subacute endocarditis} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{421.0}}: Acute and subacute bacterial endocarditis (n=42,386)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{421.9}}: Acute endocarditis, unspecified (n=1,871)} \\ \-\ \hspace{20pt}\footnotesize{-- 422: Acute myocarditis} \\ \-\ \hspace{30pt}\footnotesize{-- 422.9: Other and unspecified acute myocarditis} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{422.90}}: Acute myocarditis, unspecified (n=553)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{422.91}}: Idiopathic myocarditis (n=689)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{422.92}}: Septic myocarditis (n=13)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{422.93}}: Toxic myocarditis (n=11)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{422.99}}: Other acute myocarditis (n=84)} \\ \-\ \hspace{20pt}\footnotesize{-- 423: Other diseases of pericardium} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{423.0}}: Hemopericardium (n=2,691)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{423.1}}: Adhesive pericarditis (n=786)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{423.2}}: Constrictive pericarditis (n=2,596)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{423.8}}: Other specified diseases of pericardium (n=5,264)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{423.9}}: Unspecified disease of pericardium (n=40,947)} \\ \-\ \hspace{20pt}\footnotesize{-- 424: Other diseases of endocardium} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{424.0}}: Mitral valve disorders (n=37,875)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{424.1}}: Aortic valve disorders (n=134,602)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{424.2}}: Tricuspid valve disorders, specified as nonrheumatic (n=311)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{424.3}}: Pulmonary valve disorders (n=76)} \\ \-\ \hspace{30pt}\footnotesize{-- 424.9: Endocarditis, valve unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{424.90}}: Endocarditis, valve unspecified, unspecified cause (n=2,105)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{424.99}}: Other endocarditis, valve unspecified (n=43)} \\ \-\ \hspace{20pt}\footnotesize{-- 425: Cardiomyopathy} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{425.0}}: Endomyocardial fibrosis (n=26)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{425.1}}: Hypertrophic cardiomyopathy (n=5,745)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{425.3}}: Endocardial fibroelastosis (n=173)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{425.4}}: Other primary cardiomyopathies (n=37,448)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{425.5}}: Alcoholic cardiomyopathy (n=1,192)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{425.9}}: Secondary cardiomyopathy, unspecified (n=606)} \\ \-\ \hspace{20pt}\footnotesize{-- 426: Conduction disorders} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.0}}: Atrioventricular block, complete (n=184,923)} \\ \-\ \hspace{30pt}\footnotesize{-- 426.1: Atrioventricular block, other and unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.10}}: Atrioventricular block, unspecified (n=5,112)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.11}}: First degree atrioventricular block (n=10,409)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.12}}: Mobitz (type) II atrioventricular block (n=22,424)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.13}}: Other second degree atrioventricular block (n=47,893)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.2}}: Left bundle branch hemiblock (n=137)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.3}}: Other left bundle branch block (n=2,671)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.4}}: Right bundle branch block (n=773)} \\ \-\ \hspace{30pt}\footnotesize{-- 426.5: Bundle branch block, other and unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.50}}: Bundle branch block, unspecified (n=168)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.51}}: Right bundle branch block and left posterior fascicular block (n=113)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.52}}: Right bundle branch block and left anterior fascicular block (n=1,038)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.53}}: Other bilateral bundle branch block (n=3,243)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.54}}: Trifascicular block (n=4,586)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.6}}: Other heart block (n=4,597)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.7}}: Anomalous atrioventricular excitation (n=1,143)} \\ \-\ \hspace{30pt}\footnotesize{-- 426.8: Other specified conduction disorders} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.81}}: Lown-Ganong-Levine syndrome (n=24)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.82}}: Long QT syndrome (n=320)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.89}}: Other specified conduction disorders (n=3,824)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{426.9}}: Conduction disorder, unspecified (n=3,112)} \\ \-\ \hspace{20pt}\footnotesize{-- 427: Cardiac dysrhythmias} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.0}}: Paroxysmal supraventricular tachycardia (n=95,692)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.1}}: Paroxysmal ventricular tachycardia (n=224,850)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.2}}: Paroxysmal tachycardia, unspecified (n=2,550)} \\ \-\ \hspace{30pt}\footnotesize{-- 427.3: Atrial fibrillation and flutter} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.31}}: Atrial fibrillation (n=1,827,322)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.32}}: Atrial flutter (n=191,799)} \\ \-\ \hspace{30pt}\footnotesize{-- 427.4: Ventricular fibrillation and flutter} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.41}}: Ventricular fibrillation (n=34,286)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.42}}: Ventricular flutter (n=528)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.5}}: Cardiac arrest (n=35,738)} \\ \-\ \hspace{30pt}\footnotesize{-- 427.6: Premature beats} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.60}}: Premature beats, unspecified (n=330)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.61}}: Supraventricular premature beats (n=7,561)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.69}}: Other premature beats (n=21,680)} \\ \-\ \hspace{30pt}\footnotesize{-- 427.8: Other specified cardiac dysrhythmias} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.81}}: Sinoatrial node dysfunction (n=442,918)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.89}}: Other specified cardiac dysrhythmias (n=513,837)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{427.9}}: Cardiac dysrhythmia, unspecified (n=14,325)} \\ \-\ \hspace{20pt}\footnotesize{-- 428: Heart failure} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.1}}: Left heart failure (n=13,843)} \\ \-\ \hspace{30pt}\footnotesize{-- 428.2: Systolic heart failure} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.20}}: Systolic heart failure, unspecified (n=49,340)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.21}}: Acute systolic heart failure (n=125,294)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.22}}: Chronic systolic heart failure (n=26,238)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.23}}: Acute on chronic systolic heart failure (n=409,008)} \\ \-\ \hspace{30pt}\footnotesize{-- 428.3: Diastolic heart failure} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.30}}: Diastolic heart failure, unspecified (n=132,599)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.31}}: Acute diastolic heart failure (n=138,792)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.32}}: Chronic diastolic heart failure (n=25,797)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.33}}: Acute on chronic diastolic heart failure (n=345,184)} \\ \-\ \hspace{30pt}\footnotesize{-- 428.4: Combined systolic and diastolic heart failure} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.40}}: Combined systolic and diastolic heart failure, unspecified (n=14,282)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.41}}: Acute combined systolic and diastolic heart failure (n=26,386)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.42}}: Chronic combined systolic and diastolic heart failure (n=6,574)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.43}}: Acute on chronic combined systolic and diastolic heart failure (n=130,340)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.9}}: Heart failure, unspecified (n=1,982)} \\ \-\ \hspace{20pt}\footnotesize{-- 429: Ill-defined descriptions and complications of heart disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.0}}: Myocarditis, unspecified (n=903)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.1}}: Myocardial degeneration (n=111)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.2}}: Cardiovascular disease, unspecified (n=4,188)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.3}}: Cardiomegaly (n=905)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.4}}: Functional disturbances following cardiac surgery (n=11,768)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.5}}: Rupture of chordae tendineae (n=354)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.6}}: Rupture of papillary muscle (n=113)} \\ \-\ \hspace{30pt}\footnotesize{-- 429.7: Certain sequelae of myocardial infarction, not elsewhere classified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.71}}: Acquired cardiac septal defect (n=750)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.79}}: Certain sequelae of myocardial infarction, not elsewhere classified, other (n=738)} \\ \-\ \hspace{30pt}\footnotesize{-- 429.8: Other ill-defined heart diseases} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.81}}: Other disorders of papillary muscle (n=29)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.82}}: Hyperkinetic heart disease (n=103)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.83}}: Takotsubo syndrome (n=7,704)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.89}}: Other ill-defined heart diseases (n=1,758)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{429.9}}: Heart disease, unspecified (n=1,930)} \\ \-\ \hspace{10pt}\footnotesize{-- 430 to 438: Cerebrovascular Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 432: Other and unspecified intracranial hemorrhage} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{432.0}}: Nontraumatic extradural hemorrhage (n=1,283)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{432.1}}: Subdural hemorrhage (n=113,064)} \\ \-\ \hspace{20pt}\footnotesize{-- 433: Occlusion and stenosis of precerebral arteries} \\ \-\ \hspace{30pt}\footnotesize{-- 433.0: Basilar artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.00}}: Occlusion and stenosis of basilar artery without mention of cerebral infarction (n=2,771)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.01}}: Occlusion and stenosis of basilar artery with cerebral infarction (n=8,783)} \\ \-\ \hspace{30pt}\footnotesize{-- 433.1: Carotid artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.10}}: Occlusion and stenosis of carotid artery without mention of cerebral infarction (n=179,091)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.11}}: Occlusion and stenosis of carotid artery with cerebral infarction (n=108,838)} \\ \-\ \hspace{30pt}\footnotesize{-- 433.2: Vertebral artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.20}}: Occlusion and stenosis of vertebral artery without mention of cerebral infarction (n=4,912)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.21}}: Occlusion and stenosis of vertebral artery with cerebral infarction (n=7,201)} \\ \-\ \hspace{30pt}\footnotesize{-- 433.3: Multiple and bilateral} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.30}}: Occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction (n=39,982)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.31}}: Occlusion and stenosis of multiple and bilateral precerebral arteries with cerebral infarction (n=22,012)} \\ \-\ \hspace{30pt}\footnotesize{-- 433.8: Other specified precerebral artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.80}}: Occlusion and stenosis of other specified precerebral artery without mention of cerebral infarction (n=1,143)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.81}}: Occlusion and stenosis of other specified precerebral artery with cerebral infarction (n=6,352)} \\ \-\ \hspace{30pt}\footnotesize{-- 433.9: Unspecified precerebral artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.90}}: Occlusion and stenosis of unspecified precerebral artery without mention of cerebral infarction (n=219)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{433.91}}: Occlusion and stenosis of unspecified precerebral artery with cerebral infarction (n=969)} \\ \-\ \hspace{20pt}\footnotesize{-- 434: Occlusion of cerebral arteries} \\ \-\ \hspace{30pt}\footnotesize{-- 434.0: Cerebral thrombosis} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{434.00}}: Cerebral thrombosis without mention of cerebral infarction (n=5,311)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{434.01}}: Cerebral thrombosis with cerebral infarction (n=53,093)} \\ \-\ \hspace{30pt}\footnotesize{-- 434.1: Cerebral embolism} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{434.10}}: Cerebral embolism without mention of cerebral infarction (n=15,077)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{434.11}}: Cerebral embolism with cerebral infarction (n=280,628)} \\ \-\ \hspace{30pt}\footnotesize{-- 434.9: Cerebral artery occlusion, unspecified} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{434.90}}: Cerebral artery occlusion, unspecified without mention of cerebral infarction (n=7,593)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{434.91}}: Cerebral artery occlusion, unspecified with cerebral infarction (n=1,595,472)} \\ \-\ \hspace{20pt}\footnotesize{-- 435: Transient cerebral ischemia} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{435.0}}: Basilar artery syndrome (n=2,544)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{435.1}}: Vertebral artery syndrome (n=2,352)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{435.2}}: Subclavian steal syndrome (n=2,847)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{435.3}}: Vertebrobasilar artery syndrome (n=27,343)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{435.8}}: Other specified transient cerebral ischemias (n=52,445)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{435.9}}: Unspecified transient cerebral ischemia (n=958,603)} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{436}}: Acute, but ill-defined, cerebrovascular disease (n=259,114)} \\ \-\ \hspace{20pt}\footnotesize{-- 437: Other and ill-defined cerebrovascular disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.0}}: Cerebral atherosclerosis (n=17,363)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.1}}: Other generalized ischemic cerebrovascular disease (n=14,791)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.2}}: Hypertensive encephalopathy (n=30,964)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.3}}: Cerebral aneurysm, nonruptured (n=10,862)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.4}}: Cerebral arteritis (n=1,065)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.5}}: Moyamoya disease (n=39)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.6}}: Nonpyogenic thrombosis of intracranial venous sinus (n=185)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.7}}: Transient global amnesia (n=18,860)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.8}}: Other ill-defined cerebrovascular disease (n=2,460)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{437.9}}: Unspecified cerebrovascular disease (n=6,412)} \\ \-\ \hspace{20pt}\footnotesize{-- 438: Late effects of cerebrovascular disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.0}}: Late effects of cerebrovascular disease, cognitive deficits (n=1,065)} \\ \-\ \hspace{30pt}\footnotesize{-- 438.1: Speech and language deficits} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.10}}: Late effects of cerebrovascular disease, speech and language deficit, unspecified (n=135)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.11}}: Late effects of cerebrovascular disease, aphasia (n=1,806)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.12}}: Late effects of cerebrovascular disease, dysphasia (n=544)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.13}}: Late effects of cerebrovascular disease, dysarthria (n=249)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.14}}: Late effects of cerebrovascular disease, fluency disorder (n=2)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.19}}: Late effects of cerebrovascular disease, other speech and language deficits (n=375)} \\ \-\ \hspace{30pt}\footnotesize{-- 438.2: Hemiplegia/hemiparesis} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.20}}: Late effects of cerebrovascular disease, hemiplegia affecting unspecified side (n=7,567)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.21}}: Late effects of cerebrovascular disease, hemiplegia affecting dominant side (n=691)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.22}}: Late effects of cerebrovascular disease, hemiplegia affecting nondominant side (n=657)} \\ \-\ \hspace{30pt}\footnotesize{-- 438.3: Monoplegia of upper limb} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.30}}: Late effects of cerebrovascular disease, monoplegia of upper limb affecting unspecified side (n=47)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.31}}: Late effects of cerebrovascular disease, monoplegia of upper limb affecting dominant side (n=11)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.32}}: Late effects of cerebrovascular disease, monoplegia of upper limb affecting nondominant side (n=9)} \\ \-\ \hspace{30pt}\footnotesize{-- 438.4: Monoplegia of lower limb} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.40}}: Late effects of cerebrovascular disease, monoplegia of lower limb affecting unspecified side (n=67)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.41}}: Late effects of cerebrovascular disease, monoplegia of lower limb affecting dominant side (n=6)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.42}}: Late effects of cerebrovascular disease, monoplegia of lower limb affecting nondominant side (n=11)} \\ \-\ \hspace{30pt}\footnotesize{-- 438.5: Other paralytic syndrome} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.50}}: Late effects of cerebrovascular disease, other paralytic syndrome affecting unspecified side (n=200)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.51}}: Late effects of cerebrovascular disease, other paralytic syndrome affecting dominant side (n=14)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.53}}: Late effects of cerebrovascular disease, other paralytic syndrome, bilateral (n=120)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.6}}: Late effects of cerebrovascular disease, alterations of sensations (n=481)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.7}}: Late effects of cerebrovascular disease, disturbances of vision (n=281)} \\ \-\ \hspace{30pt}\footnotesize{-- 438.8: Other late effects of cerebrovascular disease} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.81}}: Other late effects of cerebrovascular disease, apraxia (n=207)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.82}}: Other late effects of cerebrovascular disease, dysphagia (n=8,149)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.83}}: Other late effects of cerebrovascular disease, facial weakness (n=457)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.84}}: Other late effects of cerebrovascular disease, ataxia (n=2,424)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.85}}: Other late effects of cerebrovascular disease, vertigo (n=842)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.89}}: Other late effects of cerebrovascular disease (n=47,529)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{438.9}}: Unspecified late effects of cerebrovascular disease (n=537)} \\ \-\ \hspace{10pt}\footnotesize{-- 440 to 449: Diseases Of Arteries, Arterioles, And Capillaries} \\ \-\ \hspace{20pt}\footnotesize{-- 440: Atherosclerosis} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.0}}: Atherosclerosis of aorta (n=2,559)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.1}}: Atherosclerosis of renal artery (n=24,676)} \\ \-\ \hspace{30pt}\footnotesize{-- 440.2: Of native arteries of the extremities} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.20}}: Atherosclerosis of native arteries of the extremities, unspecified (n=25,438)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.21}}: Atherosclerosis of native arteries of the extremities with intermittent claudication (n=42,792)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.22}}: Atherosclerosis of native arteries of the extremities with rest pain (n=28,691)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.23}}: Atherosclerosis of native arteries of the extremities with ulceration (n=59,047)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.24}}: Atherosclerosis of native arteries of the extremities with gangrene (n=136,553)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.29}}: Other atherosclerosis of native arteries of the extremities (n=9,431)} \\ \-\ \hspace{30pt}\footnotesize{-- 440.3: Of bypass graft of the extremities} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.30}}: Atherosclerosis of unspecified bypass graft of the extremities (n=5,573)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.31}}: Atherosclerosis of autologous vein bypass graft of the extremities (n=8,118)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.32}}: Atherosclerosis of nonautologous biological bypass graft of the extremities (n=2,256)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.8}}: Atherosclerosis of other specified arteries (n=2,020)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{440.9}}: Generalized and unspecified atherosclerosis (n=489)} \\ \-\ \hspace{20pt}\footnotesize{-- 441: Aortic aneurysm and dissection} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.1}}: Thoracic aneurysm, ruptured (n=4,338)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.2}}: Thoracic aneurysm without mention of rupture (n=11,979)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.4}}: Abdominal aneurysm without mention of rupture (n=67,216)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.5}}: Aortic aneurysm of unspecified site, ruptured (n=250)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.6}}: Thoracoabdominal aneurysm, ruptured (n=2,353)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.7}}: Thoracoabdominal aneurysm, without mention of rupture (n=5,952)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{441.9}}: Aortic aneurysm of unspecified site without mention of rupture (n=269)} \\ \-\ \hspace{20pt}\footnotesize{-- 442: Other aneurysm} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.0}}: Aneurysm of artery of upper extremity (n=640)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.1}}: Aneurysm of renal artery (n=547)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.2}}: Aneurysm of iliac artery (n=5,309)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.3}}: Aneurysm of artery of lower extremity (n=11,188)} \\ \-\ \hspace{30pt}\footnotesize{-- 442.8: Of other specified artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.81}}: Aneurysm of artery of neck (n=842)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.82}}: Aneurysm of subclavian artery (n=261)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.83}}: Aneurysm of splenic artery (n=586)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.84}}: Aneurysm of other visceral artery (n=1,362)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.89}}: Aneurysm of other specified artery (n=538)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{442.9}}: Aneurysm of unspecified site (n=62)} \\ \-\ \hspace{20pt}\footnotesize{-- 443: Other peripheral vascular disease} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.0}}: Raynaud's syndrome (n=1,016)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.1}}: Thromboangiitis obliterans [Buerger's disease] (n=126)} \\ \-\ \hspace{30pt}\footnotesize{-- 443.2: Other arterial dissection} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.21}}: Dissection of carotid artery (n=459)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.22}}: Dissection of iliac artery (n=185)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.23}}: Dissection of renal artery (n=38)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.24}}: Dissection of vertebral artery (n=317)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.29}}: Dissection of other artery (n=300)} \\ \-\ \hspace{30pt}\footnotesize{-- 443.8: Other specified peripheral vascular diseases} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.82}}: Erythromelalgia (n=19)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.89}}: Other specified peripheral vascular diseases (n=8,225)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{443.9}}: Peripheral vascular disease, unspecified (n=43,309)} \\ \-\ \hspace{20pt}\footnotesize{-- 444: Arterial embolism and thrombosis} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.0}}: Of abdominal aorta (n=4,871)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.1}}: Embolism and thrombosis of thoracic aorta (n=913)} \\ \-\ \hspace{30pt}\footnotesize{-- 444.2: Of arteries of the extremities} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.21}}: Arterial embolism and thrombosis of upper extremity (n=19,155)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.22}}: Arterial embolism and thrombosis of lower extremity (n=76,139)} \\ \-\ \hspace{30pt}\footnotesize{-- 444.8: Of other specified artery} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.81}}: Embolism and thrombosis of iliac artery (n=8,557)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.89}}: Embolism and thrombosis of other specified artery (n=4,037)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{444.9}}: Embolism and thrombosis of unspecified artery (n=232)} \\ \-\ \hspace{20pt}\footnotesize{-- 445: Atheroembolism} \\ \-\ \hspace{30pt}\footnotesize{-- 445.0: Of extremities} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{445.01}}: Atheroembolism of upper extremity (n=200)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{445.02}}: Atheroembolism of lower extremity (n=2,449)} \\ \-\ \hspace{30pt}\footnotesize{-- 445.8: Of other sites} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{445.81}}: Atheroembolism of kidney (n=425)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{445.89}}: Atheroembolism of other site (n=175)} \\ \-\ \hspace{20pt}\footnotesize{-- 446: Polyarteritis nodosa and allied conditions} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.0}}: Polyarteritis nodosa (n=1,729)} \\ \-\ \hspace{30pt}\footnotesize{-- 446.2: Hypersensitivity angiitis} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.20}}: Hypersensitivity angiitis, unspecified (n=273)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.21}}: Goodpasture's syndrome (n=967)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.29}}: Other specified hypersensitivity angiitis (n=3,170)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.4}}: Wegener's granulomatosis (n=4,019)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.5}}: Giant cell arteritis (n=16,562)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.6}}: Thrombotic microangiopathy (n=2,586)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{446.7}}: Takayasu's disease (n=124)} \\ \-\ \hspace{20pt}\footnotesize{-- 447: Other disorders of arteries and arterioles} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.0}}: Arteriovenous fistula, acquired (n=745)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.1}}: Stricture of artery (n=13,983)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.2}}: Rupture of artery (n=1,538)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.3}}: Hyperplasia of renal artery (n=277)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.4}}: Celiac artery compression syndrome (n=1,522)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.5}}: Necrosis of artery (n=18)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.6}}: Arteritis, unspecified (n=6,321)} \\ \-\ \hspace{30pt}\footnotesize{-- 447.7: Aortic ectasia} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.71}}: Thoracic aortic ectasia (n=22)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.72}}: Abdominal aortic ectasia (n=11)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.73}}: Thoracoabdominal aortic ectasia (n=5)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.8}}: Other specified disorders of arteries and arterioles (n=982)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{447.9}}: Unspecified disorders of arteries and arterioles (n=191)} \\ \-\ \hspace{20pt}\footnotesize{-- 448: Disease of capillaries} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{448.0}}: Hereditary hemorrhagic telangiectasia (n=2,511)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{448.1}}: Nevus, non-neoplastic (n=1)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{448.9}}: Other and unspecified capillary diseases (n=1,253)} \\ \-\ \hspace{10pt}\footnotesize{-- 451 to 459: Diseases Of Veins And Lymphatics, And Other Diseases Of Circulatory System} \\ \-\ \hspace{20pt}\footnotesize{-- 451: Phlebitis and thrombophlebitis} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.0}}: Phlebitis and thrombophlebitis of superficial vessels of lower extremities (n=9,692)} \\ \-\ \hspace{30pt}\footnotesize{-- 451.1: Of deep vessels of lower extremities} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.11}}: Phlebitis and thrombophlebitis of femoral vein (deep) (superficial) (n=8,969)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.19}}: Phlebitis and thrombophlebitis of deep veins of lower extremities, other (n=16,853)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.2}}: Phlebitis and thrombophlebitis of lower extremities, unspecified (n=6,245)} \\ \-\ \hspace{30pt}\footnotesize{-- 451.8: Of other sites} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.81}}: Phlebitis and thrombophlebitis of iliac vein (n=303)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.82}}: Phlebitis and thrombophlebitis of superficial veins of upper extremities (n=1,584)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.83}}: Phlebitis and thrombophlebitis of deep veins of upper extremities (n=946)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.84}}: Phlebitis and thrombophlebitis of upper extremities, unspecified (n=757)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.89}}: Phlebitis and thrombophlebitis of other sites (n=1,176)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{451.9}}: Phlebitis and thrombophlebitis of unspecified site (n=356)} \\ \-\ \hspace{20pt}\footnotesize{-- {\color{ForestGreen} \textbf{452}}: Portal vein thrombosis (n=2,497)} \\ \-\ \hspace{20pt}\footnotesize{-- 453: Other venous embolism and thrombosis} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.0}}: Budd-chiari syndrome (n=250)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.1}}: Thrombophlebitis migrans (n=378)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.2}}: Other venous embolism and thrombosis of inferior vena cava (n=2,543)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.3}}: Other venous embolism and thrombosis of renal vein (n=307)} \\ \-\ \hspace{30pt}\footnotesize{-- 453.4: Acute venous embolism and thrombosis of deep vessels of lower extremity} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.40}}: Acute venous embolism and thrombosis of unspecified deep vessels of lower extremity (n=53,092)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.41}}: Acute venous embolism and thrombosis of deep vessels of proximal lower extremity (n=177,706)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.42}}: Acute venous embolism and thrombosis of deep vessels of distal lower extremity (n=70,344)} \\ \-\ \hspace{30pt}\footnotesize{-- 453.5: Chronic venous embolism and thrombosis of deep vessels of lower extremity} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.50}}: Chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity (n=488)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.51}}: Chronic venous embolism and thrombosis of deep vessels of proximal lower extremity (n=1,815)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.52}}: Chronic venous embolism and thrombosis of deep vessels of distal lower extremity (n=683)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.6}}: Venous embolism and thrombosis of superficial vessels of lower extremity (n=2,188)} \\ \-\ \hspace{30pt}\footnotesize{-- 453.7: Chronic venous embolism and thrombosis of other specified vessels} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.71}}: Chronic venous embolism and thrombosis of superficial veins of upper extremity (n=19)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.72}}: Chronic venous embolism and thrombosis of deep veins of upper extremity (n=65)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.75}}: Chronic venous embolism and thrombosis of subclavian veins (n=64)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.76}}: Chronic venous embolism and thrombosis of internal jugular veins (n=71)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.77}}: Chronic venous embolism and thrombosis of other thoracic veins (n=35)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.79}}: Chronic venous embolism and thrombosis of other specified veins (n=54)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.8}}: Acute venous embolism and thrombosis of other specified veins (n=216,215)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{453.9}}: Other venous embolism and thrombosis of unspecified site (n=2,992)} \\ \-\ \hspace{20pt}\footnotesize{-- 454: Varicose veins of lower extremities} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{454.0}}: Varicose veins of lower extremities with ulcer (n=4,007)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{454.1}}: Varicose veins of lower extremities with inflammation (n=1,460)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{454.2}}: Varicose veins of lower extremities with ulcer and inflammation (n=6,875)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{454.8}}: Varicose veins of lower extremities with other complications (n=1,329)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{454.9}}: Asymptomatic varicose veins (n=522)} \\ \-\ \hspace{20pt}\footnotesize{-- 455: Hemorrhoids} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.0}}: Internal hemorrhoids without mention of complication (n=2,243)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.1}}: Internal thrombosed hemorrhoids (n=1,512)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.2}}: Internal hemorrhoids with other complication (n=72,829)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.3}}: External hemorrhoids without mention of complication (n=472)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.4}}: External thrombosed hemorrhoids (n=1,092)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.5}}: External hemorrhoids with other complication (n=10,906)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.6}}: Unspecified hemorrhoids without mention of complication (n=604)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.7}}: Unspecified thrombosed hemorrhoids (n=288)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.8}}: Unspecified hemorrhoids with other complication (n=20,540)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{455.9}}: Residual hemorrhoidal skin tags (n=45)} \\ \-\ \hspace{20pt}\footnotesize{-- 456: Varicose veins of other sites} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.0}}: Esophageal varices with bleeding (n=8,065)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.1}}: Esophageal varices without mention of bleeding (n=918)} \\ \-\ \hspace{30pt}\footnotesize{-- 456.2: Esophageal varices in diseases classified elsewhere} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.20}}: Esophageal varices in diseases classified elsewhere, with bleeding (n=37)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.4}}: Scrotal varices (n=79)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.5}}: Pelvic varices (n=144)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.6}}: Vulval varices (n=10)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{456.8}}: Varices of other sites (n=5,544)} \\ \-\ \hspace{20pt}\footnotesize{-- 457: Noninfectious disorders of lymphatic channels} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{457.0}}: Postmastectomy lymphedema syndrome (n=421)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{457.1}}: Other lymphedema (n=4,885)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{457.2}}: Lymphangitis (n=744)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{457.8}}: Other noninfectious disorders of lymphatic channels (n=2,658)} \\ \-\ \hspace{20pt}\footnotesize{-- 458: Hypotension} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{458.0}}: Orthostatic hypotension (n=312,294)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{458.1}}: Chronic hypotension (n=1,015)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{458.2}}: Iatrogenic hypotension (n=6,678)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{458.8}}: Other specified hypotension (n=20,077)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{458.9}}: Hypotension, unspecified (n=155,634)} \\ \-\ \hspace{20pt}\footnotesize{-- 459: Other disorders of circulatory system} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.0}}: Hemorrhage, unspecified (n=24,319)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.1}}: Postphlebitic syndrome (n=318)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.2}}: Compression of vein (n=4,794)} \\ \-\ \hspace{30pt}\footnotesize{-- 459.3: Chronic venous hypertension (idiopathic)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.30}}: Chronic venous hypertension without complications (n=299)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.31}}: Chronic venous hypertension with ulcer (n=248)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.32}}: Chronic venous hypertension with inflammation (n=97)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.33}}: Chronic venous hypertension with ulcer and inflammation (n=155)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.39}}: Chronic venous hypertension with other complication (n=161)} \\ \-\ \hspace{30pt}\footnotesize{-- 459.8: Other specified disorders of circulatory system} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.81}}: Venous (peripheral) insufficiency, unspecified (n=54,285)} \\ \-\ \hspace{40pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.89}}: Other specified disorders of circulatory system (n=3,823)} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{459.9}}: Unspecified circulatory system disorder (n=1,313)} \\  
 \hline 
 
 \textbf{\emph{Group 8}}\\ 
\textbf{Odds Ratio (95\% Credible Interval) = 1.019 (1.017,1.022)} \\ \textbf{Number of Cases = 4,083,787} \\ \textbf{Group contains the following 1 ICD9 codes:} \\ \-\ \hspace{ 0pt}\footnotesize{-- 390 to 459: Diseases Of The Circulatory System} \\ \-\ \hspace{10pt}\footnotesize{-- 420 to 429: Other Forms Of Heart Disease} \\ \-\ \hspace{20pt}\footnotesize{-- 428: Heart failure} \\ \-\ \hspace{30pt}\footnotesize{-- {\color{ForestGreen} \textbf{428.0}}: Congestive heart failure, unspecified (n=4,083,787)} \\ 
 
\end{longtable}
